Progenika Inks Companion-Dx Deal with AMT, Service Pact with ARUP Labs

CEO Antonio Martinez said this week that Progenika plans to engage in more companion diagnostic deals going forward as it develops and commercializes its own tests for familial hypercholesterolemia, drug metabolism, blood group identification, and other applications.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.